Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults

Recruiting now · Phase 4 · Has a placebo group

Conditions studied: Cognitive Impairment, Mild, Dementia, Cardiovascular Diseases

In brief

PREVENTABLE is a multi-center, randomized, parallel group, placebo-controlled superiority study. Participants will be randomized 1:1 to atorvastatin 40 mg or placebo. This large study conducted in community-dwelling older adults without cardiovascular disease (CVD) or dementia will demonstrate the benefit of statins for reducing the primary composite of death, dementia, and persistent disability and secondary composites including mild cognitive impairment (MCI) and cardiovascular events.

Key facts

Study ID
NCT04262206
Run by
Duke University
People needed
20000
Starts
2020-09-01
Expected to finish
2026-12-31
Last updated by the study team
2026-06-04

Who can join

Age: 75 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.